All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

111

Reset

111 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • RGH-202Phase 21 trial

    Gedeon Richter Plc. · Social Anxiety Disorder

  • RL-007InidascaminePhase 21 trial

    Recognify Life Sciences · Cognitive Impairment Associated With Schizophrenia (CIAS), Cognitive Impairment, Schizophrenia

  • SIPI6398Phase 21 trial

    Shanghai Zhongze Therapeutics Co., Ltd. · Schizophrenia Disorder

  • SOM001-APhase 21 trial

    Somnum Pharma Inc. · Chronic Insomnia

  • SOM001-BPhase 21 trial

    Somnum Pharma Inc. · Chronic Insomnia

  • SOM001-CPhase 21 trial

    Somnum Pharma Inc. · Chronic Insomnia

  • SOM001-DPhase 21 trial

    Somnum Pharma Inc. · Chronic Insomnia

  • SP-624Phase 21 trial

    Sirtsei Pharmaceuticals, Inc. · Major Depressive Disorder

  • SPN-821Phase 21 trial

    Supernus Pharmaceuticals, Inc. · Major Depressive Disorder (MDD)

  • SYT-510Phase 21 trial

    Synendos Therapeutics AG · Generalized Anxiety Disorder

  • VV119Phase 21 trial

    Vigonvita Life Sciences · Schizophrenia

NewerPage 3 of 3

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.